Fetal RHD genotyping of cell‐free fetal DNA from RhD‐negative pregnant women can be used to guide targeted antenatal and postnatal anti‐D prophylaxis for the prevention of RhD immunization. To assure… Click to show full abstract
Fetal RHD genotyping of cell‐free fetal DNA from RhD‐negative pregnant women can be used to guide targeted antenatal and postnatal anti‐D prophylaxis for the prevention of RhD immunization. To assure the quality of clinical testing, we conducted an external quality assessment workshop with the participation of 28 laboratories.
               
Click one of the above tabs to view related content.